Comparison of the incidence of late stent thrombosis after implantation of different drug-eluting stents in the real world coronary heart disease patients: Three-year follow-up results

Chinese Medical Journal

Volumn 123, Issue 7, 2010, Pages 778-781

  Chen, Ji Lin ^a   Gao, Li Jian ^a   Yang, Yue Jin ^a   Li, Jian Jun ^a   Qiao, Shu Bin ^a   Xu, Bo ^a   Huang, Jing Han ^a   Yao, Min ^a   Qin, Xue Wen ^a   Liu, Hai Bo ^a   Yong Jian, Wu ^a   Yuan, Jin Qing ^a   Chen, Jue ^a   You, Shi Jie ^a   Dai, Jun ^a   Gao, Run Lin ^a  

^a FUWAI HOSPITAL   (China)

Author keywords

Coronary heart disease; Drug eluting stents; Late stent thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; PACLITAXEL; RAPAMYCIN;

ADULT; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; ISCHEMIC HEART DISEASE; LATE STENT THROMBOSIS; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; STENT THROMBOSIS;

AGED; ASPIRIN; CORONARY DISEASE; CORONARY THROMBOSIS; DRUG-ELUTING STENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; RETROSPECTIVE STUDIES; TICLOPIDINE;

EID: 77950893573     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2010.07.003     Document Type: Article

References (19)

1. Caixeta A, Leon MB, Lansky AJ, Nikolsky E, Aoki J, Moses JW. Five-year clinical outcomes after sirolimus-eluting stent implantation insights from a patient-level pooled analysis of 4 randomized trials comparing sirolimus-eluting stents with bare-metal stents. J Am Coll Cardiol 2009; 54: 894-902.
2. Ellis SG, Stone GW, Cox DA, Hermiller J, O'Shaughnessy C, Mann T, et al. Long-term safety and efficacy with paclitaxel-eluting stents: 5-year final results of the TAXUS IV clinical trial (TAXUS IV-SR: Treatment of De Novo Coronary Disease Using a Single Paclitaxel-Eluting Stent. JACC Cardiovasc Interv 2009; 2: 1248-1259.
3. Stone GW, Moses JW, Ellis SG, Schofer J, Dawkins KD, Morice MC, et al. Satety and efficacy of sirolimus and paclitaxel-eluting coronary stents. N Eng J Med 2007; 356:998-l008
4. Chen JL, Yang YJ, Gao LJ, Huang JH, Qin XW, Qiao SB, et al. Incidence of thrombosis after implantation of drug-eluting stents in patients with coronary artery disease. Chin Med J 2008; 121: 2144-2147.
5. Dou KF, Xu B, Yang YJ, Chen JL, Qiao SB, Li JJ, et al. Two-year clinical outcome after successful implantation of drug-eluting and bare metal stents in diabetic patients: results from a real-world single center registry. Chin Med J 2009; 122:612-616.
6. Han YL, Zhang J, Li Y, Wang SL, Jing QM, Yi XH, et al. Long-term outcomes of drug-eluting versus bare-metal stent implantation in patients with chronic total coronary artery occlusions. Chin Med J 2009; 122: 643-647.
7. Liu HB, Xu B, Yang YJ, Wang Y, Qin XW, Yao M, et al. Long-term clinical outcomes after bioabsorbable polymer and durable polymer-based sirolimus-eluting stents implantation: two-year follow-up results from a large single-center database. Chin Med J 2009; 122: 681-686.
8. Gao RL, Xu B, Chen JL, Yang YJ, Qiao SB, Wang Y, et al. Two-year clinical outcomes following elective drug-eluting versus bare-metal stent implantation: results from a large single-center database. Chin Med J 2009; 122: 2261-2267.
9. Xu B, Zhang Q, Yang YJ, Qiao SB, Zhang RY, Zhang JS, et al. Sirolimus-eluting cobalt-chromium stents: two-year clinical results from first-in-man study on the Firebird 2 stent. Chin Med J 2008; 121: 492-497.
10. Spaulding C, Daemen J, Boersma E, Cutlip DE, Serruys PW. A pooled analysis of data comparing sirolimus-eluting stents with bare-metal stents. N Eng J Med 2007; 356: 989-997.
11. Kastrati A, Mehilli J, Pache J, Kaiser C, Valgimigli M, Kelbaek H, et al. Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents. N Eng J Med 2007; 356: 1030-1039.
12. Mauri L, Hsieh WH, Massaro JM, Ho KK, D'Agostino R, Cutlip DE. Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med 2007; 356: 1020-1029.
13. Chen JL, Yang YJ, Huang JH, Qin XW, Qiao SB, Yao M, et al. The incidence of stent thrombosis after drug-eluting stent implanted in the real world coronary artery disease. Chin J Cardiol (Chin) 2007; 35: 1133-1135.
14. Sangiorgi G, Romagnoli E, Biondi-Zoccai G, Margheri M, Tamburino C, Barbagallo R, et al. Percutaneous coronary implantation of sirolimus-eluting stents in unselected patients and lesions: clinical results and multiple outcome predictors. Am Heart J 2008; 156: 871-878.
15. De la Torre-Hernández JM, Alfonso F, Hernández F, Elizaga J, Sanmartin M, Pinar E, et al. Drug-eluting stent thrombosis: results from the multicenter Spanish registry ESTROFA (Estudio ESpañol sobre TROmbosis de stents FArmacoactivos). J Am Coll Cardiol 2008; 51: 986-990.
16. Weisz G, Leon MB, Holmes DR Jr, Kereiakes DJ, Popma JJ, Teirstein PS, et al. Five-year follow-up after sirolimus-eluting stent implantation results of the SIRIUS (Sirolimus-Eluting Stent in De-Novo Native Coronary Lesions) Trial. J Am Coll Cardiol 2009; 53: 1488-1497.
17. Daemen J, Wenaweser P, Tsuchida K, Abrecht L, Vaina S, Morger C, et al. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet 2007; 369: 667-678.
18. Iakovou I, Schmidt T, Bonizzoni E, Ge L, Sangiorgi GM, Stankovic G, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005; 293: 2126-2130.
19. Nakazawa G, Finn AV, Joner M, Ladich E, Kutys R, Mont EK, et al. Delayed arterial healing and increased late stent thrombosis at culprit sites after drug-eluting stent placement for acute myocardial infarction patients: an autopsy study. Circulation 2008; 118: 1138-1145.